Remdesivir Suppliers & Bulk Manufacturers
Available Forms: Lyophilized powder for IV & Injection
Available Strengths: Powder(100 mg/vial); Injection: 100 mg/20 mL (5 mg/mL)
Reference Brands: Veklury® (EU & US)
Category: Anti Covid Medicines
Remdesivir is available in Lyophilized powder for IV & Injection and strengths such as Powder(100 mg/vial); Injection: 100 mg/20 mL (5 mg/mL). Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Remdesivir is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Remdesivir can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description: Remdesivir (Veklury) is a broad-spectrum antiviral approved in the EU and US for the treatment of hospitalized COVID-19 patients. Manufactured by Gilead Sciences, Remdesivir is available as a 100 mg lyophilized powder and 100 mg/20 mL injection solution. As a key product in critical care, it is in demand across hospitals, distributors, and government tenders. Pharmab2B platforms connect verified Remdesivir suppliers, manufacturers, and wholesalers for compliant sourcing. Ensure regulatory-approved procurement in Europe and the United States through trusted B2B pharmaceutical networks offering competitive pricing, supply reliability, and global shipping.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Baricitinib
Strength:
2 mg, 4 mg
Form: Tablet
Reference Brands: Olumiant®(EU & US- Emergency Use Authorization (EUA)
View Details
Nirmatrelvir + Ritonavir
Strength:
Nirmatrelvir(150 mg) + Ritonavir(100 mg)
Form: Tablet
Reference Brands: Paxlovid®(US & EU- For Emergency Use Authorization)
View Details
Tocilizumab
Strength:
IV: 80 mg/4 mL, 200 mg/10 mL, 400 mg/20 mL; SQ: 162 mg/0.9 mL (pen or syringe)
Form: IV injection, SQ Injection
Reference Brands: Actemra®(US); RoActemra®(EU)
View Details
Quick Response Guaranteed | Verified Suppliers
